Beacrica

Evaluating the interactions of molecules

  • CEO: Per Källblad
  • First investment year: 2009
  • Fund: Eastern Mid Sweden
  • Business sector: Life Science

Beactica

Beactica is a specialist drug discovery company, utilising its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. As well as progressing its own drug discovery programmes, Beactica offers partnerships for fragment-based lead generation using its proprietary discovery platform.